As of 2026-08-21, Utah Medical Products Inc (UTMD) has a 3-month relative strength percentile of 66 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 54. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.1%, relative volume 3.40×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
UTMD is in a stage 2 uptrend, week 4. Currently in a 39-day base; basing ADR 3.5% (broad 2.6%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 2.5% / 11.6%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
UTMD is held by 13 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $1M notional. Top 3 carry $2M.
Held by 38 ETFs · $22M across latest filings · largest weight 0.26% (AIMS).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $1M | — |
| AVSC | 0.01% | $381K | — |
| VTWV | 0.01% | $155K | — |
| AVUSAvantis U.S. Equity ETF | 0.00% | $43K | — |
| OMFS | 0.01% | $39K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $15K | — |
| ITWO | 0.01% | $9K | — |
| URTY | 0.00% | $8K | — |
| UWM | 0.00% | $7K | — |
| MSSM | 0.00% | $5K | — |
Showing 10 of 13 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | UTMD Jan avg: -1.40% median: -3.17% win: 25% σ: 7.76% n: 4 2022-04-12 → 2026-07-31 | UTMD Feb avg: -1.33% median: -1.51% win: 25% σ: 8.42% n: 4 2022-04-12 → 2026-07-31 | UTMD Mar avg: -2.08% median: -2.33% win: 50% σ: 5.13% n: 4 2022-04-12 → 2026-07-31 | UTMD Apr avg: -2.24% median: -2.27% win: 40% σ: 5.41% n: 5 2022-04-12 → 2026-07-31 | UTMD May avg: 2.31% median: 1.83% win: 80% σ: 2.85% n: 5 2022-04-12 → 2026-07-31 | UTMD Jun avg: 0.88% median: -0.28% win: 40% σ: 2.58% n: 5 2022-04-12 → 2026-07-31 | UTMD Jul avg: 3.19% median: 4.18% win: 80% σ: 3.45% n: 5 2022-04-12 → 2026-07-31 | UTMD Aug avg: 0.84% median: -0.85% win: 50% σ: 7.98% n: 4 2022-04-12 → 2026-07-31 (current) | UTMD Sep avg: -3.41% median: -3.85% win: 25% σ: 3.92% n: 4 2022-04-12 → 2026-07-31 | UTMD Oct avg: -3.89% median: -6.40% win: 25% σ: 6.01% n: 4 2022-04-12 → 2026-07-31 | UTMD Nov avg: 1.35% median: 1.20% win: 50% σ: 3.95% n: 4 2022-04-12 → 2026-07-31 | UTMD Dec avg: 1.57% median: -0.39% win: 25% σ: 7.96% n: 4 2022-04-12 → 2026-07-31 |